Prostemics Co. Ltd (203690) — Capital Reinvestment Ratio

Latest as of December 2021: 5.52x

Prostemics Co. Ltd (203690) has a Capital Reinvestment Ratio of 5.52x as of December 2021, meaning it reinvests 6% of its operating cash flow (₩3.13 Billion) in capital expenditures (₩17.30 Billion). For the full cash flow conversion analysis, see 203690 cash flow metrics.

Capital Reinvestment Ratio

5.52x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.13 Billion
KRW

Capital Expenditures

₩17.30 Billion
KRW

Data as of

Dec 2021
Most recent filing

Prostemics Co. Ltd Capital Reinvestment Ratio (2015–2021)

This chart tracks Prostemics Co. Ltd's Capital Reinvestment Ratio across 3 annual periods. Check 203690 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Annual Capital Reinvestment Ratio for Prostemics Co. Ltd (2015–2021)

Year-by-year Capital Reinvestment Ratio for Prostemics Co. Ltd from 2015 to 2021. See Prostemics Co. Ltd (203690) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2021 5.76x ₩3.00 Billion ₩17.30 Billion ▲ +474.9%
2016 1.00x ₩5.86 Billion ₩5.87 Billion ▼ -12.1%
2015 1.14x ₩6.25 Billion ₩7.12 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow